Victrix Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.13M Buy
28,068
+2,351
+9% +$548K 2.99% 10
2026
Q1
$6.29M Buy
25,717
+1,660
+7% +$387K 2.28% 12
2025
Q4
$4.98M Sell
24,057
-28
-0.1% -$5.54K 1.93% 17
2025
Q3
$4.47M Buy
24,085
+766
+3% +$131K 2.45% 15
2025
Q2
$3.56M Buy
23,319
+182
+0.8% +$28K 1.58% 24
2025
Q1
$3.69M Buy
23,137
+137
+0.6% +$21.4K 1.94% 17
2024
Q4
$3.33M Buy
+23,000
New +$3.56M 2.4% 15

Other funds holding JNJ

Victrix Investment Advisors's JNJ Position: Q2 2026 in Review

Victrix Investment Advisors increased its Johnson & Johnson (JNJ) stake by 9.1% in Q2 2026, buying an estimated $548K and bringing the position to 28,068 shares worth $7.13M. The position accounts for 2.99% of the portfolio, ranked #10.

Victrix Investment Advisors first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 2,122 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Victrix Investment Advisors held 28,068 shares of Johnson & Johnson worth $7.13M as of Q2 2026.
  • Victrix Investment Advisors bought 2,351 Johnson & Johnson shares in Q2 2026, an estimated $548K.
  • Johnson & Johnson made up 2.99% of Victrix Investment Advisors's portfolio in Q2 2026, its #10 holding.
  • Victrix Investment Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 2,122 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Victrix Investment Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.